Navigation Links
MicroPhage Closes Latest Financing
Date:11/20/2008

LONGMONT, Colo., Nov. 20 /PRNewswire/ -- MicroPhage, Inc., http://www.microphage.com, today announced it has concluded its latest round of financing, which brings total capital raised to $11 million. Investors in this round were a combination of existing and new investors. All funds to date have come from private investors.

MicroPhage will apply proceeds of its financing to complete the validation and launch preparation of their initial diagnostic products, which address the growing need for simple, rapid and highly accurate tests for hospital-acquired infections (HAIs), such as MRSA.

R. Gary Mesch, chairman of MicroPhage commented "MicroPhage investors are confident the company will deliver badly needed diagnostic tools in the fight against MRSA and other HAIs. Closing a significant funding round in this tough financial climate is a noteworthy achievement."

MicroPhage CEO Steve Lundy added: "We have been validating our products in the field and have received excellent feedback from laboratory professionals who tested them against current methods. We are looking forward to completing our validation work and launching products, which leverage the tremendous power of bacteriophage amplification technology for rapid bacterial identification and susceptibility testing."

About MicroPhage

Based in Longmont, Colo. and privately held, MicroPhage, Inc. is working to be a global leader in developing rapid diagnostics products for bacterial identification and antibiotic susceptibility/resistance testing. Using its bacteriophage-based amplification platform, the company has developed a patented process that is a product platform or engine for rapid, easy-to-use, inexpensive diagnostic tests. Its first products, expected in late 2009, will set a new standard for clinicians in MRSA identification and antibiotic susceptibility testi
'/>"/>

SOURCE MicroPhage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing
2. CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
3. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
4. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
5. Great Basin Scientific, Inc. Closes $3.9 Million in Equity Funding
6. Micromet Closes $40 Million Private Equity Placement
7. Helix Biopharma Closes $11.4 Million Private Placement
8. ForteBio, Inc. Closes $25 Million In Series C Financing
9. AMDL, Inc. Closes Private Placement of Convertible Notes
10. World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round
11. Pathwork Diagnostics Closes $20M Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Chromium - Global Market Trends ,...m---Global-Market-Trends.html ,, Worldwide dem...ess steel, while growth in aerospace and industria... of chromium metal. Environmental constraints and ...
(Date:12/1/2009)... Harvest Technologies Corp. ( www.h...company sponsored 60-patient clinical trial conduc...India using the company,s BMAC System to treat pat...mia (CLI). Sri Ramachandra Medical Center is a Har...based in Chennai, India and one of the largest pri...
(Date:12/1/2009)...RNewswire-Asia/ -- Shanghai ChemPartner, as the,fl...based Contract Research,Organization (CRO), today ...nology Fast 50 China, ranking 3rd on the list of t...he award is a testament to ChemPartner,s outstandi..., The results of the 2009 Deloitte Technolo...
(Date:12/1/2009)...RNewswire/ -- The Burrill Biotech Select Index man... October. The Select,s gain of 4.5 percent mirrore... markets with the Dow up 6.5 percent and the NASDA...the final two trading days of the month despite in... shopping and Dubai,s reported debt woes. ,, Al...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...PEL HILL, N.C., June 18 To thrive in today,s,comp...ers need to,understand that a winning sales perfor...ain, structure, deploy, and lead their sales force...nsure high success rates., Best Practices LLC,s r... allow their sales forces to evolve and mature to ...
...d As A Regular Part Of Georgetown University Hospi...ronic Wounds, PRINCETON, N.J., June 18 Derma Sci...vanced wound care products,announced today that it...,with Active Leptospermum Honey, has been used by ...nd Center to save a patient,s limb. The clinicians...
... YORK, June 18 Danube Pharmaceuticals, Inc., a,pr...g in the commercial,research and development of in...nounce the appointment of Dr. Barrett Katz, MD, MB...and delighted to join Danube Pharmaceuticals at th...its lead programs through,clinical trials and brin...
Other Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 3Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 4Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3
(Date:12/2/2009)...he first identification of substances involved in ...rmless marine bacteria into killers that cause "co...onmental Science & Technology , a semi-monthly jou...aching already has destroyed up to 30 percent of t...ng for ways to slow or stop the damage. One known ...
(Date:12/2/2009)...HORES, Calif. and PALM HARBOR, Fla., Dec. 2 /PRNew...poration ("CIC") (OTC Bulletin Board: CICI), a lea...r business process automation in the financial ind...gnature verification and Docubase Systems Inc. ("D...ment Management (EDM) software provider announced ...
(Date:12/2/2009)...inders of carbon about a nanometer in diameterhave...h as ultrastrong fibers, electrical wires in molec...uel cells. Thanks to a new development by research...hnology (NIST) and five partners, you can add one ...ction of an aggressive form of breast cancer. , ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2FDA Acts to Protect Public Health from Electronic Cigarettes 52470 1FDA Acts to Protect Public Health from Electronic Cigarettes 52470 2FDA Acts to Protect Public Health from Electronic Cigarettes 52470 3Regence Wins Four Telly Awards for Health and Wellness Videos 52468 1Regence Wins Four Telly Awards for Health and Wellness Videos 52468 2President Obama Asks for COSEs Input on Health Care Reform Plan 52467 1President Obama Asks for COSEs Input on Health Care Reform Plan 52467 2
...se is available in German . , Animals "personall...l partners, mating, fertilizing, and reproducing. ... the help of a third party, the pollinator, which ...en to receptive stigmas frequently over large dist... their volatile signals and nectar attract and rew...
...sed in Switzerland and South Africa have created a... hearing deficits, and potentially remedy even sub...d of retuning functioning regions of the ear to re...aged areas. Details are published August 29th in t... . , Hearing loss is an increasingly important pr...
... genetically induced excess baggage may have helpe... marine ancestors, according to a UBC study publis... to 10 centimetres long, stickleback fish originat...kes and streams following the last ice age. Over t...n in evolutionary terms - freshwater sticklebacks ...
Other Biology News:Bitter-tasting nectar and floral odors optimize outcrossing for plants 2Bitter-tasting nectar and floral odors optimize outcrossing for plants 3Bitter-tasting nectar and floral odors optimize outcrossing for plants 4Biophysical method may help to recover hearing 2'Armored' fish study helps strengthen Darwin's natural selection theory 2
Rabbit Anti-MacMarcks Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...EW HandyStep electronic from BRAND adds ergonomics...ly electronic, motor-driven repeating pipette comp...BRAND PD-Tip syringe tips, Eppendorf Combi-Tips an...VWRbrand Combi-Syringes. Select virtually any pipe...
StrepMAB-Immo coated microplate; 96 well from IBA GmbH
PyAOP from Applied Biosystems
Biology Products: